Top compounds associated with response to KCND3


Feature Type Standardized
Nominal ANOVA
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.12 0.0008
mRNA AZD6244 CTRPv2 pan-cancer AAC -0.12 0.0008
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 0.0009
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.001
mRNA paclitaxel UHNBreast pan-cancer AAC -0.82 0.001
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.001
mRNA PD318088 CTRPv2 pan-cancer AAC -0.11 0.001
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA pluripotin CTRPv2 pan-cancer AAC -0.11 0.001
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
Download CSV